Myocardial stimulation threshold in patients with cardiac pacemakers: effect of physiologic variables, pharmacologic agents, and lead electrodes.
Many factors affect the threshold for myocardial stimulation in patients with cardiac pacemakers. The acute local tissue reaction at the electrode-myocardium interface accounts for early threshold rises and may be minimized by choice of specific electrodes (steroid-eluting or carbon-tip). Physiologic variations due to changes in autonomic tone (including eating, sleeping, and exercise) account for day-to-day fluctuations in pacing threshold. Electrolyte and metabolic abnormalities, especially hyperkalemia, alkalosis, acidosis, and hyperglycemia, increase the pacing threshold. Commonly used antiarrhythmic drugs (quinidine and procainamide) also increase pacing threshold. Patients with pacemakers who require antiarrhythmic agents or who have coincident metabolic or electrolyte disturbances should be observed closely for failure to capture. Management of failure to capture is directed at removing the inciting cause and attempting to lower the pacing threshold with isoproterenol, if the situation is urgent. Acute increases in pacing threshold immediately following pacing system implantation can be treated with corticosteroids. Increasing the energy output of programmable pacemakers, in specific circumstances, or insertion of a temporary pacemaker capable of delivering higher energy output than the implanted generator may also be successful.
D000889:Anti-Arrhythmia Agents / Q000494:pharmacology; D002304:Cardiac Pacing, Artificial / Q000379:methods; D004566:Electrodes; D004573:Electrolytes / Q000097:blood; D006321:Heart / Q000187:drug effects / Q000503:physiopathology*; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology; D013566:Sympathomimetics / Q000494:pharmacology
D000889:Anti-Arrhythmia Agents; D004573:Electrolytes; D013566:Sympathomimetics; D007545:Isoproterenol